Cargando…

Prognostic Value of Plasma and Urine Glycosaminoglycan Scores in Clear Cell Renal Cell Carcinoma

BACKGROUND: The prognosis of metastatic clear cell renal cell carcinoma (ccRCC) vastly improved since the introduction of antiangiogenic-targeted therapy. However, it is still unclear which biological processes underlie ccRCC aggressiveness and affect prognosis. Here, we checked whether a recently d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gatto, Francesco, Maruzzo, Marco, Magro, Cristina, Basso, Umberto, Nielsen, Jens
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2016
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5121125/ https://www.ncbi.nlm.nih.gov/pubmed/27933273 http://dx.doi.org/10.3389/fonc.2016.00253

Ejemplares similares

Analysis of normal levels of free glycosaminoglycans in urine and plasma in adults
por: Bratulic, Sinisa, et al.
Publicado: (2022)

Plasma and Urine Free Glycosaminoglycans as Monitoring Biomarkers in Nonmetastatic Renal Cell Carcinoma—A Prospective Cohort Study
por: Gatto, Francesco, et al.
Publicado: (2022)

Plasma Glycosaminoglycans as Diagnostic and Prognostic Biomarkers in Surgically Treated Renal Cell Carcinoma
por: Gatto, Francesco, et al.
Publicado: (2018)

Plasma and Urine Free Glycosaminoglycans as Monitoring and Predictive Biomarkers in Metastatic Renal Cell Carcinoma: A Prospective Cohort Study
por: Gatto, Francesco, et al.
Publicado: (2023)

Prognostic Value of YTHDF2 in Clear Cell Renal Cell Carcinoma
por: Mu, Zhongyi, et al.
Publicado: (2020)

Excavation of diagnostic biomarkers and construction of prognostic model for clear cell renal cell carcinoma based on urine proteomics
por: Yang, Yiren, et al.
Publicado: (2023)

Prognostic Value of Thyroid Hormone Ratio in Patients With Advanced Metastatic Renal Cell Carcinoma: Results From the Threefour Study (Meet-URO 14)
por: Maruzzo, Marco, et al.
Publicado: (2021)

Prognostic value of neutrophil extracellular trap signature in clear cell renal cell carcinoma
por: Li, Rong, et al.
Publicado: (2023)

The Prognostic Value of Programmed Death-Ligand 1 in a Chinese Cohort With Clear Cell Renal Cell Carcinoma
por: Xiao, Wen-jun, et al.
Publicado: (2019)

Integrative Bioinformatics Analysis Demonstrates the Prognostic Value of Chromatin Accessibility Biomarkers in Clear Cell Renal Cell Carcinoma
por: Meng, Meng, et al.
Publicado: (2021)

Nivolumab drug holiday in patients treated for metastatic renal cell carcinoma: A real-world, single-centre experience
por: Bimbatti, Davide, et al.
Publicado: (2022)

Prognostic Value of Tumor-Associated Macrophages in Clear Cell Renal Cell Carcinoma: A Systematic Review and Meta-Analysis
por: Shen, Haixiang, et al.
Publicado: (2021)

Prognostic value of systemic immune-inflammation index in non-metastatic clear cell renal cell carcinoma with tumor thrombus
por: Gu, Yufeng, et al.
Publicado: (2023)

Review of Prognostic Expression Markers for Clear Cell Renal Cell Carcinoma
por: Petitprez, Florent, et al.
Publicado: (2021)

Comprehensive Analysis of ATP6V1s Family Members in Renal Clear Cell Carcinoma With Prognostic Values
por: Li, Xiaojuan, et al.
Publicado: (2020)

A simple method for detecting oncofetal chondroitin sulfate glycosaminoglycans in bladder cancer urine
por: Clausen, Thomas Mandel, et al.
Publicado: (2020)

Prognostic Stratification of Metastatic Prostate Cancer Patients Treated With Abiraterone and Enzalutamide Through an Integrated Analysis of Circulating Free microRNAs and Clinical Parameters
por: Sharova, Evgeniya, et al.
Publicado: (2021)

Identification of an Autophagy-Related Prognostic Signature for Clear Cell Renal Cell Carcinoma
por: Chen, Mei, et al.
Publicado: (2020)

Integrative Analysis of Sirtuins and Their Prognostic Significance in Clear Cell Renal Cell Carcinoma
por: Tan, Ying, et al.
Publicado: (2020)

The Prognostic Value of Radiomics Features Extracted From Computed Tomography in Patients With Localized Clear Cell Renal Cell Carcinoma After Nephrectomy
por: Tang, Xin, et al.
Publicado: (2021)

Prognostic value of normal sodium levels in patients with metastatic renal cell carcinoma receiving tyrosine kinase inhibitors
por: Roviello, Giandomenico, et al.
Publicado: (2022)

The expression and prognostic value of transporter 1, ATP binding cassette subfamily B member in clear cell renal cell cancer with experimental validation
por: Wang, Zhen-Da, et al.
Publicado: (2022)

Identification of CXCL10 as a Prognostic Biomarker for Clear Cell Renal Cell Carcinoma
por: Qu, Genyi, et al.
Publicado: (2022)

The stratification and prognostic importance of molecular and immune landscapes in clear cell renal cell carcinoma
por: Zhai, Xinyu, et al.
Publicado: (2023)

Advanced Non-Clear Cell Renal Cell Carcinoma Treatments and Survival: A Real-World Single-Centre Experience
por: Bimbatti, Davide, et al.
Publicado: (2023)

The CSRNP Gene Family Serves as a Prognostic Biomarker in Clear Cell Renal Cell Carcinoma
por: Zhang, Huaru, et al.
Publicado: (2021)

Expression of basement membrane genes and their prognostic significance in clear cell renal cell carcinoma patients
por: Tao, Junyue, et al.
Publicado: (2022)

Comprehensive Analysis of the Expression and Prognosis Value of Chromobox Family Members in Clear Cell Renal Cell Carcinoma
por: Zhu, Yuanyuan, et al.
Publicado: (2021)

The core genes of cuproptosis assists in discerning prognostic and immunological traits of clear cell renal cell carcinoma
por: Chu, Binxiang, et al.
Publicado: (2022)

Exploring a ferroptosis and oxidative stress-based prognostic model for clear cell renal cell carcinoma
por: Lin, Dongxu, et al.
Publicado: (2023)

Flux balance analysis predicts essential genes in clear cell renal cell carcinoma metabolism
por: Gatto, Francesco, et al.
Publicado: (2015)

Identification of the Prognosis Value and Potential Mechanism of Immune Checkpoints in Renal Clear Cell Carcinoma Microenvironment
por: Liao, Guodong, et al.
Publicado: (2021)

A Novel Prognostic Signature Associated With the Tumor Microenvironment in Kidney Renal Clear Cell Carcinoma
por: Pei, Dongchen, et al.
Publicado: (2022)

Prognostic biomarker NEIL3 and its association with immune infiltration in renal clear cell carcinoma
por: Sun, Xiaomei, et al.
Publicado: (2023)

A New Prognostic Risk Signature of Eight Ferroptosis-Related Genes in the Clear Cell Renal Cell Carcinoma
por: Chen, Ji, et al.
Publicado: (2021)

Differentially Expressed Genes in Clear Cell Renal Cell Carcinoma as a Potential Marker for Prognostic and Immune Signatures
por: Tong, Ying, et al.
Publicado: (2021)

Integrative analysis of transcriptomic landscape and urinary signature reveals prognostic biomarkers for clear cell renal cell carcinoma
por: Zhang, Wei, et al.
Publicado: (2023)

Importance of metabolic and immune profile as a prognostic indicator in patients with diabetic clear cell renal cell carcinoma
por: Cheng, Xiangyu, et al.
Publicado: (2023)

Prognostic Value of the Neo-Immunoscore in Renal Cell Carcinoma
por: Guo, Congfang, et al.
Publicado: (2019)

Editorial: The ever-changing scenario of first line treatment of metastatic renal cell carcinoma
por: Vitale, Maria Giuseppa, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_t5a0u7me2jjpna39fq0uimu2d8